Therapeutic Asset Ratings

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Abemaciclib Estrogen-Receptor Positive Breast Cancer	Jonsson Comprehensive Cancer Center	P3	BB (67)
Acetylcysteine Pulmonary Fibrosis	Boehringer Ingelheim	P3	BB (67)
Adriamycin Fallopian Tube Neoplasm	Eli Lilly and Company	P3	BB (67)
Aoc 1044 Duchenne Muscular Dystrophy	Avidity Biosciences, Inc.	P3	BB (67)
ask120067 Non-Small Cell Lung Carcinoma	Jiangsu Aosaikang Pharmaceutical Co., Ltd.	P3	BB (67)
Atezolizumab Ovarian Carcinoma	OHSU Knight Cancer Institute	P3	BB (67)
Atumelnant Classic Congenital Adrenal Hyperplasia	Crinetics Pharmaceuticals Inc.	P3	BB (67)
Atumelnant Congenital Adrenal Hyperplasia	Crinetics Pharmaceuticals Inc.	P3	BB (67)
Autologous Cd34+ Cells Isolated From Mobilised Peripheral Blood By Positive Selection, Modified By Crispr/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/Crispr-Associated Protein 9) Mediated Gene Editing Consisting Of A Guide Rna (Grna) Introduced Transiently As Ribonucleoprotein (Rnp) Complex, Targeting The Erythroid Lineage-Specific Enhancer Region Of Bcl11A (B-Cell Lymphoma/Leukemia 11A). The Site-Specific Cleavage By Cas9 Forms A Double Strand Break (Dsb), Which Is Subsequently Repaired By Nonhomologous End-Joining (Nhej), Leading To The Transcriptional Repression Of Bcl11A, A Repressor Of ?-Globin Gene Transcription Beta Thalassemia	Daniel Bauer	P3	BB (67)
Axs-05 Alzheimer Disease	Axsome Therapeutics, Inc.	P3	BB (67)
Bexicaserin Developmental And Epileptic Encephalopathy	Longboard Pharmaceuticals	P3	BB (67)
Busulfanum Acute Myeloid Leukemia With 11q23 Abnormalities	M.D. Anderson Cancer Center	P3	BB (67)
Busulfanum Disease Related To Transplantation	M.D. Anderson Cancer Center	P3	BB (67)
Calaspargase Pegol Lymphoblastic Lymphoma	Children's Oncology Group	P3	BB (67)
Camizestrant Breast Cancer	AstraZeneca	P3	BB (67)
Camustine Glioblastoma	Leland Metheny	P3	BB (67)
Capecitabine Diffuse Large B-Cell Lymphoma	Genmab	P3	BB (67)
Capecitabine Gallbladder Cancer	Merck Sharp & Dohme LLC	P3	BB (67)
Capecitabine Pancreatic Neoplasm	Tianjin Medical University Cancer Institute and Hospital	P3	BB (67)
Carboplatin Fallopian Tube Neoplasm	Eli Lilly and Company	P3	BB (67)
Carboplatin Peritoneal Carcinoma	CanariaBio Inc.	P3	BB (67)
Catequentinib Refractory Malignant Neoplasm	Nanfang Hospital, Southern Medical University	P3	BB (67)
Cediranib Cutaneous Melanoma	Jonsson Comprehensive Cancer Center	P3	BB (67)
Cetuximab Colon Adenocarcinoma	Merck Sharp & Dohme LLC	P3	BB (67)
Clofarabine Acute Myeloid Leukemia With 11q23 Abnormalities	M.D. Anderson Cancer Center	P3	BB (67)

Showing 1676 to 1700 of 42,301 assets

PreviousPage 68 of 1693Next